Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adam Scott Feldman, M.D.

Co-Author

This page shows the publications co-authored by Adam Feldman and Mukesh G Harisinghani.
Connection Strength

1.169
  1. The potential of nanoparticle-enhanced imaging. Urol Oncol. 2008 Jan-Feb; 26(1):65-73.
    View in: PubMed
    Score: 0.371
  2. Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification. Urol Oncol. 2022 02; 40(2):59.e1-59.e5.
    View in: PubMed
    Score: 0.240
  3. Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer. J Urol. 2019 11; 202(5):944-951.
    View in: PubMed
    Score: 0.210
  4. Diversion ahead: imaging appearance of urinary diversions and reservoirs. Clin Imaging. 2014 Jul-Aug; 38(4):418-427.
    View in: PubMed
    Score: 0.142
  5. Reply by Authors. J Urol. 2022 01; 207(1):94.
    View in: PubMed
    Score: 0.060
  6. Transperineal multiparametric magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy combined with standard template improves perineural invasion detection. Hum Pathol. 2021 11; 117:101-107.
    View in: PubMed
    Score: 0.060
  7. Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy Combined with Standard Template Improves Prostate Cancer Detection. J Urol. 2022 01; 207(1):86-94.
    View in: PubMed
    Score: 0.060
  8. Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis. Radiology. 2010 Sep; 256(3):836-46.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.